Clinuvel股价目标被Wilsons下调4%,至A$30.16/股
道琼斯08/30 07:23
Morgans Financial将Clinuvel Pharmaceuticals的评级从持有升级为增持;目标价为AU$16
MT Newswires08/23 16:43
Jefferies将Clinuvel Pharmaceuticals的目标价格下调14%,至39.70澳元/股。
道琼斯08/22 11:56
摩根金融将Clinuvel药品股票的评级从加入到持有降级;价格目标为16澳元
MT Newswires07/08 15:35
摩根财务上调Clinuvel Pharmicals的持仓资格;目标股价为16澳元
MT Newswires03/14 11:00
暂无数据